Yasuo Terauchi

ORCID: 0000-0002-8872-3697
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Diabetes Treatment and Management
  • Metabolism, Diabetes, and Cancer
  • Diabetes Management and Research
  • Pancreatic function and diabetes
  • Diabetes and associated disorders
  • Adipose Tissue and Metabolism
  • Peroxisome Proliferator-Activated Receptors
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Pharmacology and Obesity Treatment
  • Adipokines, Inflammation, and Metabolic Diseases
  • Liver Disease Diagnosis and Treatment
  • Diet, Metabolism, and Disease
  • Diabetes Management and Education
  • Diet and metabolism studies
  • Regulation of Appetite and Obesity
  • Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Lipoproteins and Cardiovascular Health
  • Cardiovascular Function and Risk Factors
  • Growth Hormone and Insulin-like Growth Factors
  • Chronic Kidney Disease and Diabetes
  • Pancreatitis Pathology and Treatment
  • Endoplasmic Reticulum Stress and Disease
  • Obstructive Sleep Apnea Research
  • Gastric Cancer Management and Outcomes
  • Neuroendocrine Tumor Research Advances

Yokohama City University
2016-2025

Japan Association for Diabetes Education and Care
2011-2024

Yokohama City University Hospital
2013-2023

Yokohama City University Medical Center
2008-2021

Kyoto University
2021

Yamato University
2020

Nagoya City University
2020

Fujisawa City Hospital
2018-2019

Chigasaki Rehabilitation College
2018

Advanced Materials Enterprises (China)
2018

The adipocyte-derived hormone adiponectin has been proposed to play important roles in the regulation of energy homeostasis and insulin sensitivity, it reported exhibit putative antiatherogenic properties <i>in vitro</i>. In this study we generated adiponectin-deficient mice directly investigate whether a physiological protective role against diabetes atherosclerosis vivo</i>. Heterozygous (<i>adipo</i> <sup>+/−</sup>) showed mild resistance, while homozygous <sup>−/−</sup>) moderate...

10.1074/jbc.c200251200 article EN cc-by Journal of Biological Chemistry 2002-07-01

The adipocyte-derived hormone adiponectin has been shown to play important roles in the regulation of energy homeostasis and insulin sensitivity. In this study, we analyzed globular domain (gAd) transgenic (Tg) mice crossed with leptin-deficient ob/ob or apoE-deficient mice. Interestingly, despite an unexpected similar body weight, gAd Tg showed amelioration resistance β-cell degranulation as well diabetes, indicating that leptin appeared have both distinct overlapping functions....

10.1074/jbc.m209033200 article EN cc-by Journal of Biological Chemistry 2003-01-01

Based on the fact that aging is associated with a reciprocal decrease of osteogenesis and an increase adipogenesis in bone marrow osteoblasts adipocytes share common progenitor, this study investigated role PPARγ, key regulator adipocyte differentiation, metabolism. Homozygous PPARγ-deficient ES cells failed to differentiate into adipocytes, but spontaneously differentiated osteoblasts, these were restored by reintroduction PPARγ gene. Heterozygous mice exhibited high mass increased...

10.1172/jci19900 article EN Journal of Clinical Investigation 2004-03-15

Based on the fact that aging is associated with a reciprocal decrease of osteogenesis and an increase adipogenesis in bone marrow osteoblasts adipocytes share common progenitor, this study investigated role PPARγ γ, key regulator adipocyte differentiation, metabolism.Homozygous γ-deficient ES cells failed to differentiate into adipocytes, but spontaneously differentiated osteoblasts, these were restored by reintroduction γ gene.Heterozygous mice exhibited high mass increased...

10.1172/jci200419900 article EN Journal of Clinical Investigation 2004-03-15

Peroxisome proliferator-activated receptor (PPAR) γ is a ligand-activated transcription factor and member of the nuclear hormone superfamily that thought to be master regulator fat storage; however, relationship between PPARγ insulin sensitivity highly controversial. We show here supraphysiological activation by agonist thiazolidinediones (TZD) markedly increases triglyceride (TG) content white adipose tissue (WAT), thereby decreasing TG liver muscle, leading amelioration resistance at...

10.1074/jbc.m103241200 article EN cc-by Journal of Biological Chemistry 2001-11-01

Adiponectin/Acrp30 is a hormone secreted by adipocytes, which acts as an antidiabetic and antiatherogenic adipokine. We reported previously that AdipoR1 -R2 serve receptors for adiponectin mediate increased fatty acid oxidation glucose uptake adiponectin. In the present study, we examined expression levels roles of AdipoR1/R2 in several physiological pathophysiological states such fasting/refeeding, obesity, insulin resistance. Here show target organs, skeletal muscle liver, significantly...

10.1074/jbc.m402367200 article EN cc-by Journal of Biological Chemistry 2004-07-01

To investigate the role of insulin receptor substrate (IRS)-2 in vivo, we generated IRS-2-deficient mice by gene targeting. Although homozygous (IRS-2-/- mice) had a body weight similar to wild-type mice, they progressively developed type 2 diabetes at 10 weeks. IRS-2-/- showed resistance and defect insulin-stimulated signaling pathway liver but not skeletal muscle. Despite resistance, amount beta-cells was reduced 83% that which marked contrast 85% increase IRS-1-deficient (IRS-1-/-...

10.2337/diabetes.49.11.1880 article EN Diabetes 2000-11-01

Glucose metabolism in glycolysis and mitochondria is pivotal to glucose-induced insulin secretion from pancreatic β cells. One or more factors derived other than pyruvate appear be required for the generation of mitochondrial signals that lead secretion. The electrons glycolysis-derived reduced form nicotinamide adenine dinucleotide (NADH) are transferred through NADH shuttle system. By abolishing function, increases autofluorescence, membrane potential, adenosine triphosphate content were...

10.1126/science.283.5404.981 article EN Science 1999-02-12

Mice with a targeted gene disruption of p85α, regulatory subunit phosphoinositide 3-kinase, had impaired B cell development at the pro–B stage, reduced numbers mature cells and peritoneal CD5 + Ly-1 cells, proliferative responses, no T cell–independent antibody production. These phenotypes are nearly identical to those Btk −/− or xid (X-linked immunodeficiency) mice. results provide evidence that p85α is functionally linked pathway in antigen receptor–mediated signal transduction pivotal functions.

10.1126/science.283.5400.390 article EN Science 1999-01-15
Vanita R. Aroda Julio Rosenstock Yasuo Terauchi Yüksel Altuntaş Nebojsa M. Lalic and 95 more Enrique C. Morales Villegas Ole K. Jeppesen Erik Christiansen CHRISTIN L. HERTZ Martin Haluzı́k Krim Belkacem Nabil Chiali Samia Bourezane R. Guermaz P. Popivanov Ivaylo Lefterov Tsvetalina Tankova I Penchev Martina Košková Miroslava Hudcova A. Veselá Anna Rancova Martin Haluzı́k Arihiro Kiyosue Osamu Matsuoka Satoshi Inoue Yasuo Terauchi Yasushi Fukushima Yumiko Ide R. Ortiz Enrique Villegas Albina Golovach Diana Alpenidze Elena Frolova Elena Zhdanova Ludmila Ruyatkina О. Б. Ершова Ю. Г. Самойлова S. T. Zyangirova Katarina Lalić Nebojša Lalić Teodora Beljić Živković Hayriye Esra Ataoğlu Okan Bakıner A. D. Dayan Mehmet Sargın Meral Mert Mine Adaş Ömür Tabak Yüksel Altuntaş Alexander V. Murray Ali Iranmanesh Aron Schlau Bram Wieskopf Brian D. Snyder Carl J. Griffin Charles Fogarty Charles Lovell Dale C. Allison David Fitzpatrick David Grant David C. Klonoff Dwayne Williams Eddie Armas Eileen Palace Gary Ruoff Gilbert Martinez Gilberto Perez Harold Bays Horia Tatu James Maynard Jeanne-Elyse Cedeno Vanita R. Aroda Jean Park Jennefer Sutton Joe Pouzar John Bertsch Jonathan Condit Jorge Serje Josel Cabaccan Joseph Risser Juan P. Frías Julio Rosenstock Kanagaratnam Sivalingam Kelli Maw Lenita Hanson Liana K. Billings Lisa Connery Mario Juarez Michael Lillestol Neil Fraser Paul Beckett Ralph Wade Raul Gaona Richard F. W. Jackson Robert DeLuca Sady Alpizar Sharon J. Herring Stanley Stringam Steven M. Bauer

OBJECTIVE This trial compared the efficacy and safety of first oral glucagon-like peptide 1 (GLP-1) receptor agonist, semaglutide, as monotherapy with placebo in patients type 2 diabetes managed by diet exercise alone. Two estimands addressed two efficacy-related questions: a treatment policy estimand (regardless product discontinuation or rescue medication use) (on without all randomized patients. RESEARCH DESIGN AND METHODS was 26-week, phase 3a, randomized, double-blind,...

10.2337/dc19-0749 article EN Diabetes Care 2019-06-11

Glucokinase (Gck) functions as a glucose sensor for insulin secretion, and in mice fed standard chow, haploinsufficiency of β cell–specific Gck (Gck+/–) causes impaired secretion to glucose, although the animals have normal cell mass. When high-fat (HF) diet, wild-type showed marked hyperplasia, whereas Gck+/– demonstrated decreased replication insufficient hyperplasia despite showing similar degree resistance. DNA chip analysis revealed receptor substrate 2 (Irs2) expression HF diet–fed...

10.1172/jci17645 article EN Journal of Clinical Investigation 2007-01-02

Thiazolidinediones have been shown to up-regulate adiponectin expression in white adipose tissue and plasma levels, these up-regulations proposed be a major mechanism of the thiazolidinedione-induced amelioration insulin resistance linked obesity. To test this hypothesis, we generated knock-out (adipo-/-) ob/ob mice with C57B/6 background. After 14 days 10 mg/kg pioglitazone, diabetes were significantly improved association significant up-regulation serum levels. Amelioration was attributed...

10.1074/jbc.m505649200 article EN cc-by Journal of Biological Chemistry 2006-01-24
Kohjiro Ueki Takayoshi Sasako Yukiko Okazaki Masayuki Kato Sumie Okahata and 95 more Hisayuki Katsuyama Mikiko Haraguchi Ai Morita Ken Ohashi Kazuo Hara Atsushi Morise Kazuo Izumi Naoki Ishizuka Yasuo Ohashi Mitsuhiko Noda Takashi Kadowaki Masakazu Haneda Yasunori Iwashima Toshihiro Suda Naoki Tamasawa Makoto Daimon Jo Satoh Noriko Takebe Yasushi Ishigaki Tsuyoshi Watanabe Hiroaki Satoh Kikuo Kasai Yoshimasa Aso Shun Ishibashi Shigehiro Katayama San‐e Ishikawa Masafumi Kakei Kazuyuki Namai Naotake Hashimoto Yoshifumi Suzuki Shunichiro Onishi Koutaro Yokote Masafumi Matsuda Masahiro Masuzawa Yoichi Hayashi Satoshi Saitô Norikazu Ogihara Hisamitsu Ishihara Naoko Tajima Kazunori Utsunomiya Akira Shimada Hiroshi Itoh Ryuzo Kawamori Hirotaka Watada Michio Hayashi Yasumichi Mori Teruo Shiba Akihiro Isogawa Hiroshi Sakura Masato Odawara Kazuyuki Tobe Kazuhisa Tsukamoto Toshimasa Yamauchi Tamio Teramoto Yukio Hirata Isao Uchimura Yoshihiro Ogawa Gen Yoshino Takahisa Hirose Hiroshi Kajio Yoshihito Atsumi Akira Shimada Yoichi Oikawa Atsushi Araki Akio Ueki Atsushi Ohno Masafumi Kitaoka Yoshikuni Fujita Tatsumi Moriya Taiki Tojo Masayoshi Shichiri Daisuke Suzuki Masao Toyoda Kumiko Hamano Rieko Komi Yasuo Terauchi Nobuaki Kuzuya Masayo Yamada Toshinari Takamura Mitsuo Imura Hiroshi Tanaka Masayuki Hayashi Yasuhisa Kato Mitsuyasu Itoh Atsushi Suzuki Mikihiro Nakayama Takahisa Sano Eitaro Nakashima Yasuhiro Sumida Yutaka Yano Tsuyoshi Tanaka Kazuya Murata Atsunori Kashiwagi Hiroshi Maegawa Shigeo Kono

10.1016/s2213-8587(17)30327-3 article EN publisher-specific-oa The Lancet Diabetes & Endocrinology 2017-10-24

Diet composition alters the metabolic states of adipocytes and hepatocytes in diabetes. The effects dipeptidyl peptidase-4 (DPP-4) inhibition on adipose tissue inflammation fatty liver have been obscure. We investigated extrapancreatic DPP-4 visceral fat liver.We diet-induced changes β-cell-specific glucokinase haploinsufficient (Gck(+/-)) diabetic mice. challenged animals with a diet containing combination sucrose oleic acid (SO) or linoleic (SL). Next, we assessed inhibitor,...

10.2337/db10-1338 article EN cc-by-nc-nd Diabetes 2011-02-18

In recent years, several oral antidiabetic drugs with new mechanisms of action have become available, expanding the number treatment options. Sodium/glucose cotransporter-2 (SGLT2) inhibitors are a class an insulin-independent mechanism promoting urinary glucose excretion. We report results combined Phase 2 and 3 clinical study (Japic CTI-101349) SGLT2 inhibitor tofogliflozin (CSG452, RG7201) in Japanese patients type diabetes mellitus. The efficacy safety were assessed this multicenter,...

10.1186/1475-2840-13-65 article EN cc-by Cardiovascular Diabetology 2014-01-01

PPARγ is a ligand-activated transcription factor and functions as heterodimer with retinoid X receptor (RXR). Supraphysiological activation of by thiazolidinediones can reduce insulin resistance hyperglycemia in type 2 diabetes, but these drugs also cause weight gain. Quite unexpectedly, moderate reduction activity observed heterozygous PPARγ-deficient mice or the Pro12Ala polymorphism human PPARγ, has been shown to prevent obesity induced high-fat diet. In this study, we investigated...

10.1172/jci12864 article EN Journal of Clinical Investigation 2001-10-01
Coming Soon ...